YorkBridge Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-681
Closed -$309K 264
2022
Q3
$309K Sell
681
-161
-19% -$77K 0.08% 189
2022
Q2
$406K Buy
+842
New +$417K 0.11% 150
2019
Q3
Sell
-1,138
Closed -$321K 309
2019
Q2
$321K Sell
1,138
-226
-17% -$61.7K 0.14% 132
2019
Q1
$391K Sell
1,364
-52
-4% -$15K 0.18% 114
2018
Q4
$372K Hold
1,416
0.2% 112
2018
Q3
$391K Hold
1,416
0.18% 119
2018
Q2
$337K Sell
1,416
-107
-7% -$24.8K 0.15% 137
2018
Q1
$336K Hold
1,523
0.15% 130
2017
Q4
$351K Sell
1,523
-23
-1% -$4.9K 0.17% 125
2017
Q3
$294K Hold
1,546
0.15% 133
2017
Q2
$293K Hold
1,546
0.16% 129
2017
Q1
$280K Buy
1,546
+54
+4% +$8.59K 0.15% 136
2016
Q4
$216K Buy
+1,492
New +$200K 0.13% 152

Other funds holding ELV

YorkBridge Wealth Partners's ELV Position: Q4 2022 in Review

YorkBridge Wealth Partners sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 681 shares — an estimated $309K sold.

YorkBridge Wealth Partners first reported a position in ELV in Q4 2016 and held it in 13 quarters. The position peaked at $406K in Q2 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • YorkBridge Wealth Partners reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 681 Elevance Health shares in Q4 2022, an estimated $309K.
  • YorkBridge Wealth Partners first reported a position in Elevance Health in Q4 2016 and held it in 13 quarters.
  • YorkBridge Wealth Partners's Elevance Health position peaked at $406K in Q2 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.